Paper Details

  1. Home
  2. Paper Details

Interferon beta-1b treatment in patients with relapsing--remitting multiple sclerosis under a standardized protocol in Spain.

Author: Alvarez-CermeñoJ C, ArbizuT, DecapG, FernándezO, García MerinoA, IzquierdoG, MontalbánX, UríaD F

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study analyzed data on the use of interferon beta-1b (IFNbeta-1b) in Spain. The data were collected from several health services and compiled into a database to assess the real-world performance of IFNbeta-1b in a clinical setting.
Paper Details　
Original Abstract of the Article :
A protocol system is being used in Spain for the prescription of innovative drugs including interferon beta-1b (IFNbeta-1b). Petitions for dispensing and reimbursement are based on the inclusion and exclusion criteria of pivotal trials, and are reviewed individually for approval by specialist commit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1034/j.1600-0404.2000.102004209.x

データ提供：米国国立医学図書館（NLM）

Interferon Beta-1b Treatment in Multiple Sclerosis: A Standardized Protocol

This study delves into the world of neurology, investigating the effectiveness of interferon beta-1b (IFNbeta-1b) in treating relapsing-remitting multiple sclerosis (RRMS). The researchers are exploring how this medication performs in a real-world setting, analyzing data from a standardized protocol used in Spain.

A Glimpse into the Effectiveness of IFNbeta-1b

The study analyzed data from a large population of patients with RRMS treated with IFNbeta-1b under a standardized protocol, providing valuable insights into the medication's effectiveness in routine clinical practice.

Dr. Camel's Conclusion

This study provides valuable data on the effectiveness of IFNbeta-1b in treating RRMS, highlighting the importance of standardized protocols in ensuring consistent and effective care for patients with this complex condition.
Date :
  1. Date Completed 2001-05-31
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

11071104

DOI: Digital Object Identifier

10.1034/j.1600-0404.2000.102004209.x

Related Literature

Article Analysis
・Side Effects of interferon beta-1b injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.